Showing results (131-140 of 276) with videos related to
Sort By:
Pageof 28
Clinical and Vaccine Immunology : CVI|May 18, 2012
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodiesPatricia M Day, Yuk-Ying S Pang, Rhonda C Kines, et al.International Immunology|April 20, 2001
Physical interaction of human papillomavirus virus-like particles with immune cellsD M Da Silva, M P Velders, J D Nieland, et al.Mucosal Immunology|September 13, 2012
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in miceS Domingos-Pereira, L Decrausaz, L Derré, et al.Gynecologic Oncology|April 22, 2004
A population-based study of cervical carcinoma and HPV infection in LatviaIlvars Silins, Xiaohong Wang, Amha Tadesse, et al.International Journal of Cancer|January 21, 2006
Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 miceJiahua Qian, Yujun Dong, Yuk-Ying S Pang, et al.NPJ Vaccines|April 25, 2025
Repurposing anti-viral subunit and mRNA vaccines T cell immunity for intratumoral immunotherapy against solid tumorsShiv K Sethi, Claire E Bradley, Lukas Bialkowski, et al.Virology|November 15, 1994
Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopesN D Christensen, R Kirnbauer, J T Schiller, et al.Journal of Virology|September 1, 1993
Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domainB D Cohen, D J Goldstein, L Rutledge, et al.Vaccine|September 5, 2006
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancerEduardo L Franco, F Xavier Bosch, Jack Cuzick, et al.Vaccine|September 5, 2006
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international expertsThomas C Wright, F Xavier Bosch, Eduardo L Franco, et al.Pageof 28